Vesicular dysfunction during experimental thiamine deficiency is indicated by alterations in dopamine metabolism

European Journal of Pharmacology

Volumn 317, Issue 2-3, 1996, Pages 263-267

  Mousseau, Darrell D ^a,b   Rao, V L Raghavendra ^a   Butterworth, Roger F ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

3 Methoxytyramine; Monoamine oxidase; Wernicke Korsakoff syndrome

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); KETANSERIN; METHYSERGIDE; PYRITHIAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN REGION; CATECHOLAMINE METABOLISM; DOPAMINE METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPTOMATOLOGY; SYNAPSE VESICLE; THIAMINE DEFICIENCY; WERNICKE KORSAKOFF SYNDROME;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIMETABOLITES; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CATECHOLAMINES; DOPAMINE; KETANSERIN; MALE; NOREPINEPHRINE; PYRITHIAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS; SYNAPTIC VESICLES; TETRABENAZINE; THIAMINE DEFICIENCY;

EID: 0030593909     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00842-4     Document Type: Article

References (20)

1. Iwata, H., T. Nishikawa and A. Baba, 1970, Catecholamine accumulation in tissues of thiamine-deficient rats after inhibition of monoamine oxidase, Eur. J. Pharmacol. 12, 253.
2. Iwata, H., K. Watanabe, T. Nishikawa and M. Ohashi, 1969, Effects of drugs on behavior, heart rate and catecholamine levels in thiamine-deficient rats, Eur. J. Pharmacol. 6, 83.
3. Karoum, F., S.J. Chrapusta and M.F. Egan, 1994, 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model, J. Neurochem. 63, 972.
4. Kopelman, M.D., 1995, The Korsakoff syndrome, Br. J. Psychiatry 166, 154.
5. Krobert, K.A., R.L. Sutton and D.M. Feeney, 1994, Spontaneous and amphetamine-evoked release of cerebellar noradrenaline after sensorimotor cortex contusion: an in vivo microdialysis study in the awake rat, J. Neurochem. 62, 2233.
6. Langlais, P.J., R.G. Mair, C.D. Anderson and W.J. McEntee, 1987, Monoamines and metabolites in cortex and subcortical structures: normal regional distribution and the effects of thiamine deficiency in the rat, Brain Res. 421, 140.
7. Langlais, P.J., R.G. Mair, C.D. Anderson and W.J. McEntee, 1988, Long-lasting changes in regional brain amino acids and monoamines in recovered pyrithiamine treated rats, Neurochem. Res. 13, 1199.
8. 3H]ketanserin binding sites in striatal membranes are associated with a DOPAC release system on dopaminergic nerve endings, Eur. J. Pharmacol. 134, 373.
9. Mair, R.G. and W.J. McEntee, 1986, Cognitive enhancement in Korsakoff's disease by clonidine: a comparison with L-DOPA and ephedrine, Psychopharmacology 88, 274.
10. Mair, R.G., W.J. McEntee and R.J. Zatorre, 1985, Monoamine activity correlates with psychometric deficits in Korsakoff's disease, Behav. Brain Res. 15, 247.
11. Mair, R.G., C.D. Anderson, P.J. Langlais and W.J. McEntee, 1988, Behavioral impairments, brain lesions and monoaminergic activity in the rat following recovery from a bout of thiamine deficiency, Behav. Brain Res. 27, 223.
12. McEntee, W.J. and R.G. Mair, 1978, Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity, Science 202, 905.
13. McEntee, W.J. and R.G. Mair, 1980, Memory enhancement in Korsakoff's psychosis: further evidence of a noradrenergic deficit, Ann. Neurol. 27, 466.
14. Mousseau, D.D., V.L.R. Rao and R.F. Butterworth, 1996a, Alterations in serotonin parameters in brain of thiamine deficient rats are evident prior to the appearance of neurological symptoms, J. Neurochem. 67, 1113.
15. +-ATPase activity is selectively increased in thalamus in thiamine deficiency prior to the appearance of neurological symptoms, Eur. J. Pharmacol. 300, 191.
16. O'Donnell, V.M., W.M. Pitts and W.E. Fann, 1986, Noradrenergic and cholinergic agents in Korsakoff's syndrome, Clin. Neuropharmacol. 9, 65.
17. Pasinetti, G.M., D.G. Morgan, S.A. Johnson, S.L. Millar and C.E. Finch, 1990, Tyrosine hydroxylase mRNA concentrations in midbrain dopaminergic neurons is differentially regulated by reserpine, J. Neurochem. 55, 1793.
18. Vogel, S. and A.M. Hakim, 1988, Effect of nimodipine on the regional cerebral acidosis accompanying thiamine deficiency in the rat, J. Neurochem. 51, 1102.
19. Yu, P.H., B.A. Davis, J. Fang and A.A. Boulton, 1994, Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus, J. Neurochem. 63, 1820.
20. Zhang, S.X., G.S. Weilersbacher, S.W. Henderson, T. Corso, J.W. Olney and P.J. Langlais, 1995, Excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions. J. Neuropathol. Exp. Neurol. 54, 255.